Oxygenta Pharmaceutical Ltd.

Market Capital

₹106 Cr.

P/E

0.00

Share Price

₹ 31.35 -0.33 (-1.04%)

Oxygenta Pharmaceutical Ltd.
Overview
Financials
Benchmarking
Shareholding

Oxygenta Pharmaceutical Ltd.

Oxygenta Pharmaceutical Ltd.
Overview
Financials
Benchmarking
Shareholding

Price
Growth Table
Balance Sheet
Profit & Loss
Cash Flow
Cash Flow Analysis
Ratios
Quarterly Results
Reverse DCF

Price

₹ 31.35 -0.33 (-1.04%)

CHART MODE

Price

CHART MODE

EV/EBITDA

Price to Sales

Price to Book

CHART MODE

Capex

CHART MODE

Debt

Growth Table

Oxygenta Pharmaceutical Ltd.

(in %)	1yr	2yr	3yr	4yr	5yr	6yr	7yr	8yr	9yr	10yr
Share Price CAGR	18.35	-3.17	62.98	44.24	27.71	16.72	16.38	19.5	6.45	15.94
TTM EPS CAGR	—	—	—	—	—	—	—	—	—	—
Sales CAGR	-38.85	-35.93	28.57	—	—	—	—	22.89	24.73	—
PAT Margin (Abs Growth)	-6.64	41.19	14.86	-1.01	-1.01	10.61	—	—	—	—
Show More
Show Less
PE CAGR	—	—	—	—	—	—	—	—	—	—
CFO CAGR	3.58	-19.5	-40.04	—	—	—	-12.52	-5.73	11.91	24.03

* Share price and PE growth are updated everyday. All other fields are as of latest financial year end. EPS adjusted for bonus and splits.

BALANCE SHEET

| View Detailed

(in Rs. Cr.)	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Assets	21.16	18.62	33.86	31.18	54.26
Non Current Assets	11.07	10.72	16.58	20.15	29.26
Net Block	11.90	11.42	16.31	19.98	27.91
Capital Work in Progress	0	0	0.65	0.34	—
Intangible Assets Under Development	—	—	—	—	—
Long Term Investments	0.05	0.05	0.05	0.05	0.05
Show More
Show Less
Current Assets	8.80	6.77	15.94	9.56	25.01
Inventory	5.33	4.25	12.11	7.28	11.71
Accounts Receivable	0.51	0.42	1.61	1.58	10.16
Short Term Investments	—	—	—	—	—
Cash & Bank Balances	0.02	0.12	0.45	0.16	0.02
Show More
Show Less
Show More
Show Less
Liabilities	21.16	18.62	33.86	31.18	54.26
Shareholders Funds	-35.16	-40.95	-38.02	-34.63	-46.20
Share Capital	10.20	10.20	10.20	14.20	14.20
Reserves	-45.36	-51.15	-48.22	-48.83	-60.40
Show More
Show Less
Non Current Liabilities	39.59	43.72	54.39	57.76	74.42
Secured Loans	0.50	0.50	—	—	—
Unsecured Loans	20.37	24.94	45.04	51.04	63.02
Show More
Show Less
Current Liabilities	16.73	15.85	17.50	8.04	26.04
Accounts Payable	8.95	8.10	13.79	6.46	20.00
Short Term Loans	0.49	0.50	2.85	1.09	4.97
Show More
Show Less
Show More
Show Less

(in Rs. Cr.)	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Assets	21.16	18.62	33.86	31.18	54.26
Non Current Assets	11.07	10.72	16.58	20.15	29.26
Gross Block	24.58	25.10	31.18	36.44	—
Less: Accumulated Depreciation	12.68	13.68	14.87	16.46	—
Less: Impairment of Assets	—	—	—	—	—
Net Block	11.90	11.42	16.31	19.98	27.91
Lease Adjustment A/c	—	—	—	—	—
Capital Work in Progress	0	0	0.65	0.34	—
Long Term Investments	0.05	0.05	0.05	0.05	0.05
Long Term Loans & Advances	0.41	0.38	0.91	1.24	0.42
Other Non Current Assets	0	0	0	—	—
Show More
Show Less
Current Assets	8.80	6.77	15.94	9.56	25.01
Inventory	5.33	4.25	12.11	7.28	11.71
Accounts Receivable	0.51	0.42	1.61	1.58	10.16
Short Term Investments	—	—	—	—	—
Cash & Bank Balances	0.02	0.12	0.45	0.16	0.02
Other Current Assets	0.38	0.04	0.05	0.01	3.04
Short Term Loans and Advances	2.56	1.93	1.72	0.54	—
Show More
Show Less
Show More
Show Less
Liabilities	21.16	18.62	33.86	31.18	54.26
Shareholders Funds	-35.16	-40.95	-38.02	-34.63	-46.20
Share Capital	10.20	10.20	10.20	14.20	14.20
Share Warrants	—	—	—	—	—
Reserves	-45.36	-51.15	-48.22	-48.83	-60.40
Show More
Show Less
Non Current Liabilities	39.59	43.72	54.39	57.76	74.42
Secured Loans	0.50	0.50	—	—	—
Unsecured Loans	20.37	24.94	45.04	51.04	63.02
Deferred Tax Assets/Liabilities	1.28	1.13	1.34	1.46	—
Other Long Term Liabilities	3.46	2.62	2.12	—	—
Long Term Provisions	—	—	2.66	2.53	—
Show More
Show Less
Current Liabilities	16.73	15.85	17.50	8.04	26.04
Accounts Payable	8.95	8.10	13.79	6.46	20.00
Short Term Loans	0.49	0.50	2.85	1.09	4.97
Other Current Liabilities	6.31	6.27	0.77	0.38	—
Share Application Money	—	—	—	—	—
Show More
Show Less
Short Term Provisions	0.98	0.97	0.09	0.12	0.52
Show More
Show Less
Show More
Show Less

Balance Sheet Snapshot

+ Add a Comparison

Fund Flow Analysis

+ Add a Comparison

Increase
Decrease
Total

*Data is as of latest FY end

Profit & Loss

| View Detailed

(in Rs. Cr.)	Mar 2019	Mar 2020	Mar 2021	Mar 2022	TTM
Sales	20.51	13.72	52.03	60.52	28.98
Operating Expenses	22.55	21.58	48.18	59.05	38.67
Raw Material	18.23	14.51	43.02	42.67	28.61
Others	18.23	14.51	43.02	42.67
Show More
Show Less
Employee Cost	2.71	2.50	4.08	4.48	1.16
Power & Fuel Cost	0.89	1.00	2.79	3.04	—
Show More
Show Less
Operating Profit	-2.04	-7.87	3.84	1.48	-9.69
Other Income	0.31	0.03	0.09	0.00	0.00
Depreciation and Amortisation Expenses	1.02	1.00	1.20	1.59	2.15
Interest	0.75	1.09	1.78	0.92	1.53
Profit Before Tax	-3.49	-5.94	3.14	-0.49	-14.24
Tax	-0.24	-0.15	0.21	0.12	0.20
Net Profit	-3.25	-5.79	2.93	-0.61	-14.44
Number of shares(Crs)	—	1.02	1.02	1.42	—
Dividend Payout Ratio	0	0	0	0	—

*TTM Values as of Jun 2023

(in Rs. Cr.)	Mar 2019	Mar 2020	Mar 2021	Mar 2022	TTM
Gross Sales	20.51	13.72	52.03	60.52	—
Less: Excise Duty	—	—	—	—	—
Net Sales	20.51	13.72	52.03	60.52	28.98
Operating Expenses	22.55	21.58	48.18	59.05	38.67
Raw Material	18.23	14.51	43.02	42.67	28.61
Others	18.23	14.51	43.02	42.67
Show More
Show Less
Increase/Decrease in Stock	-2.15	1.07	-6.39	4.55	-4.93
Other Manufacturing Expenses	1.38	1.32	2.88	2.41	—
Employee Cost	2.71	2.50	4.08	4.48	1.16
Selling and Distribution Expenses	0.10	0.05	0.01	0.00	—
Power & Fuel Cost	0.89	1.00	2.79	3.04	—
General and Administration Expenses	1.33	1.12	1.78	1.88	—
Miscellaneous Expenses	0.06	0.01	0.01	0.01	—
Show More
Show Less
Operating Profit	-2.04	-7.87	3.84	1.48	-9.69
Other Income	0.31	0.03	0.09	0.00	0.00
Interest	0.75	1.09	1.78	0.92	1.53
PBDT	-2.47	-8.93	2.15	0.56	-12.09
Depreciation and Amortization	1.02	1.00	1.20	1.59	2.15
Profit Before Taxation & Exceptional Items	-3.49	-9.93	0.95	-1.04	—
Exceptional Income / Expenses	—	3.99	2.19	0.55	—
Profit Before Tax	-3.49	-5.94	3.14	-0.49	-14.24
Provision for Taxs	-0.24	-0.15	0.21	0.12	0.20
Current Income Tax	—	—	—	—	—
Deferred Tax	-0.24	-0.15	0.21	0.12	—
Other taxes	0	0	0	0	—
Show More
Show Less
Profit After Tax	-3.25	-5.79	2.93	-0.61	-14.44
Extra items	—	—	0	0	0
Minority Interest	—	—	—	—	—
Share of Associate	—	—	—	—	—
Net Profit	-3.25	-5.79	2.93	-0.61	-14.44
Number of shares(Crs)	—	1.02	1.02	1.42	—
Dividend Payout Ratio	0	0	0	0	—

*TTM Values as of Jun 2023

CASH FLOW

Standalone
Consolidated

(in Rs. Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Cash from Operating Activity	-2.69	-4.28	0.85	0.52	1.28	-7.79	-2.59	-1.62	-1.68	-5.41
Profit Before Tax	-4.10	-6.85	-5.50	-5.72	-4.48	-3.49	-5.94	3.14	-0.49	-11.37
Adjustments	0.77	2.73	1.34	1.49	1.83	1.75	2.07	2.96	2.51	3.53
OCF Before Working Capital	-3.33	-4.13	-4.17	-4.23	-2.65	-1.74	-3.87	6.10	2.02	-7.84
Working Capital Changes	0.63	-0.16	5.01	4.84	3.99	-6.29	1.13	-7.51	-3.58	2.63
Taxes Paid	—	—	—	-0.09	-0.05	0.24	0.15	-0.21	-0.12	-0.20
Show More
Show Less
Cash from Investing Activity	-1.62	0.93	-2.08	-0.90	-0.39	-0.56	-0.50	-6.72	-4.94	-9.64
Net Fixed Assets Purchased	-1.72	-2.30	-2.08	-0.91	-0.41	-0.57	-0.52	-6.74	-4.95	-9.65
Fixed Assets Purchased	-1.72	-2.30	-2.08	-0.91	-0.41	-0.57	-0.52	-6.74	-4.95	-9.65
Fixed Assets Sold	—	—	—	—	—	—	—	—	—	—
Show More
Show Less
Investment Purchased	—	—	—	—	—	—	—	—	—	—
Investment Sold	—	—	—	—	—	—	—	—	—	—
Interest Recieved	0.00	0.01	—	0.01	0.02	0.01	0.02	0.02	0.00	0.01
Dividends Recieved	—	—	—	—	—	—	—	—	—	—
Subsidiary Investments	—	—	—	—	—	—	—	—	—	—
Show More
Show Less
Cash from Financing Activity	3.73	3.42	1.17	0.39	-0.90	8.36	3.19	8.67	6.33	15
Proceeds From Shares	—	—	—	—	—	—	—	—	4	—
Net Long Term Borrowings	3.92	3.90	2.11	0.99	0.00	9.10	4.28	10.45	3.26	16.49
Proceeds From Borrowings	3.92	3.90	2.11	0.99	0.00	9.10	4.28	10.45	3.26	16.49
Repayment From Borrowings	—	—	—	—	—	—	—	—	—	—
Show More
Show Less
Interest Paid	-0.01	-0.21	-0.51	-0.60	-0.90	-0.75	-1.09	-1.78	-0.92	-1.49
Dividend Paid	—	—	—	—	—	—	—	—	—	—
Show More
Show Less
Net Cash Flow	-0.58	0.07	-0.06	0.01	-0.01	0.01	0.10	0.33	-0.29	-0.05
Opening Cash & Cash Equivalents	0.59	0.01	0.08	0.01	0.02	0.01	0.02	0.12	0.45	0.16
Effect of FX	—	—	—	—	—	—	—	—	—	—
Closing Cash & Cash Equivalents	0.01	0.08	0.01	0.02	0.01	0.02	0.12	0.45	0.16	0.11
Net Capex (est)	1.72	2.30	2.08	0.91	0.41	0.57	0.52	6.74	4.95	9.65
Free Cash Flow (est)	-4.41	-6.58	-1.23	-0.39	0.87	-8.36	-3.11	-8.36	-6.63	-15.05

Cash Flow Analysis

+ Add a Comparison

Increase
Decrease
Total

Ratios

Standalone
Consolidated

= Dominant Factor

	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Operational Ratios
Quick Ratio	0.21	0.16	0.22	0.28
Liquid Assets (Crs)	3.47	2.52	3.83	2.28
Current Liabilities (Crs)	16.73	15.85	17.50	8.04
Show More
Show Less
Current Ratio	0.53	0.43	0.91	1.19
Current Assets (Crs)	8.80	6.77	15.94	9.56
Current Liabilities (Crs)	16.73	15.85	17.50	8.04
Show More
Show Less
Interest Coverage Ratio	-3.68	-4.43	2.76	0.47
EBIT (Crs)	-2.75	-8.83	2.74	-0.11
Interest Expenses (Crs)	0.75	1.09	1.78	0.92
Show More
Show Less
Fixed Asset Turnover	0.83	0.55	1.67	1.66
Net Sales (Crs)	20.51	13.72	52.03	60.52
Fixed Assets (Crs)	24.58	25.10	31.18	36.44
Show More
Show Less
Cash Conversion Cycle	-74.64	-59.76	-44.52	-10.16
Inventory Days	61.29	128	57.41	58.49
Days Receivable	8.84	12.49	7.13	9.61
Days Payable	145	200	109	78.25
Show More
Show Less
Debt to Equity Ratio	-0.64	-0.66	-1.26	-1.51
Total Debt (Crs)	22.34	26.92	47.89	52.13
Shareholders Equity (Crs)	-35.16	-40.95	-38.02	-34.63
Show More
Show Less
Free Cash Flow/Sales (%)	-40.78	-22.69	-16.07	-10.95
Free Cash Flow(est) (Crs)	-8.36	-3.11	-8.36	-6.63
Net Sales (Crs)	20.51	13.72	52.03	60.52
Show More
Show Less
Show More
Show Less
Profitability Ratios
Op Profit Margin (%)	-8.43	-57.11	7.56	2.45
Operating Profit (Crs)	-1.73	-7.83	3.93	1.48
Net Sales (Crs)	20.51	13.72	52.03	60.52
Show More
Show Less
Net Profit Margin (%)	-15.87	-42.20	5.63	-1.01
Net Profit (Crs)	-3.25	-5.79	2.93	-0.61
Net Sales (Crs)	20.51	13.72	52.03	60.52
Show More
Show Less
ROCE (%)	-61.97	-318.41	16.73	-0.48
EBIT (Crs)	-2.75	-8.83	2.74	-0.11
Capital Employed (Crs)	4.43	2.77	16.37	23.14
Show More
Show Less
Return on Assets (%)	-15.38	-31.08	8.65	-1.96
Net Profit (Crs)	-3.25	-5.79	2.93	-0.61
Total Assets (Crs)	21.16	18.62	33.86	31.18
Show More
Show Less
ROIC (%)	-72.02	-387.92	16.48	-0.66
Op Profit after Taxes (Crs)	-2.85	-8.64	2.47	-0.14
Invested Capital (Crs)	3.96	2.23	14.97	21.69
Show More
Show Less
ROE (%)	9.25	14.13	-7.71	1.76
Net Profit Margin (%)	-15.87	-42.20	5.63	-1.01
Asset Turnover ratio	0.97	0.74	1.54	1.94
Equity Multiplier	-0.60	-0.45	-0.89	-0.90
Show More
Show Less
Adjusted EPS	-3.19	-5.67	2.87	-0.43
Show More
Show Less
Valuation Ratios
P/E	0	0	0	0
Price to Book	0	0	0	-0.99
EV/EBITDA	-18.82	-4.72	14.65	58.17
Dividend Yield (%)	—	—	—	0
Show More
Show Less

Quarterly Results

Standalone
Consolidated

(in Rs. Cr.)	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023
Net Sales	11.09	22.03	15.49	15.93	7.08	8.89	6.06	7.87	8.19	6.86
Operating Expenses	10.57	21.09	14.53	15.09	8.51	9.94	7.56	10.18	10.43	10.50
Increase/Decrease in Stock	-3.44	-2.23	4.04	2.34	0.58	-0.77	-1.13	-1.96	-0.78	-1.07
Raw Material	10.14	20.50	7.68	9.81	4.68	7.61	5.05	8.12	7.35	8.09
Employee Cost	0.22	0.11	0.07	0.07	0.08	0.14	0.29	0.27	0.42	0.18
Selling and Distribution Expenses	0	0	0	0	0	0	0	0	0	0
Electricity, Power & Fuel Cost	0	0	0	0	0	0	0	0	0	0
Gen_AdminExpenses	0	0	0	0	0	0	0	0	0	0
Miscellaneous Expenses	0	0	0	0	0	0	0	0	0	0
Show More
Show Less
Operating Profit	0.52	0.94	0.96	0.84	-1.43	-1.05	-1.50	-2.31	-2.25	-3.64
Other Income	0.07	0	0.00	0	0.00	0	0	0	0.00	0
Interest	1.33	0.24	0.30	0.22	0.16	0.25	0.10	0.20	0.94	0.29
PBDT	1.45	0.88	-0.16	0.62	-0.41	-1.29	-1.94	-2.85	-3.24	-4.06
Depreciation and Amortization	0.43	0.40	0.40	0.40	0.38	0.40	0.40	0.40	0.85	0.50
Profit Before Tax	1.02	0.47	-0.56	0.22	-0.79	-1.69	-2.34	-3.25	-4.09	-4.56
Tax	0.21	0	0	0	0.12	0	0	0	0.20	0
Profit After Tax	0.81	0.47	-0.56	0.22	-0.91	-1.69	-2.34	-3.25	-4.29	-4.56
Extra items	0	0	0	0	0	0	0	0	0	0
Net Profit	0.81	0.47	-0.56	0.22	-0.91	-1.69	-2.34	-3.25	-4.29	-4.56
Quarterly Ratios
EPS	0.79	0.46	-0.40	0.15	-0.64	-1.19	-1.65	-2.29	-3.02	-1.36
Operating Profit Margin	4.68	4.26	6.18	5.27	-20.25	-11.75	-24.77	-29.34	-27.44	-52.96
Net Profit Margin	7.28	2.15	-3.63	1.36	-12.90	-19.05	-38.59	-41.30	-52.41	-66.40
Show More
Show Less

Reverse DCF

Earnings

(Cr)

Discount Rate (%)

5 YEAR

Terminal Multiple

Implied Growth Rate over a 5 year period*

10 YEAR

Terminal Multiple

Implied Growth Rate over a 10 year period*

20 YEAR

Terminal Multiple

Implied Growth Rate over a 20 year period*

*Implied Growth calculated using Newton-Rhapson method.

Learn how to use Reverse DCF

Oxygenta Pharmaceutical Ltd.

Oxygenta Pharmaceutical Ltd.

SIGN UP FOR FREE